Skip to main content
Equibles

WELLS FARGO & COMPANY/MN

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 72971 SAN FRANCISCO, CA
Back to TSHA Full portfolio

Position in TSHA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$2,269,866
+$1,450,364 QoQ
Shares Held
333,314
+81.8% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#68
of 208 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority Sole 99% Shared 0% None 1%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

WELLS FARGO & COMPANY/MN holds $1,575,562,942 across 417 Biotechnology names. TSHA ranks #91 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 749,528 $372,313,040
2 HALO
Halozyme Therapeutics, Inc.
 1,390,428 $108,828,797
3 ALNY
Alnylam Pharmaceuticals, Inc.
 310,047 $93,333,446
4 REGN
Regeneron Pharmaceuticals, Inc.
 140,802 $87,795,677
5 EXEL
Exelixis, Inc.
 717,840 $39,057,673
6 RVMD
Revolution Medicines, Inc.
 178,780 $33,481,916
7 ARGX
Argenx SE
 34,453 $31,964,458
8 INCY
Incyte Corp
 255,064 $28,914,053

All Filings in TSHA

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,269,866 333,314
2026-03-31 $819,502 183,334
2025-12-31 $1,677,973 305,086
2025-09-30 $474,470 145,098
2025-06-30 $247,709 107,234
2025-03-31 $151,576 109,048
2024-12-31 $178,854 103,384
2024-09-30 $144,572 71,927
2024-06-30 $156,221 69,742
2024-03-31 $21,260 7,408
2023-12-31 $13,148 7,429
2023-09-30 $20,665 6,540
2023-06-30 $12,686 19,193
2023-03-31 $3,227 4,045
2022-12-31 $2,865 1,268
2022-09-30 $1,833 950
2022-06-30 $606 163
2022-03-31 $9,421 1,445
2021-12-31 $110,196 9,459
2021-03-31 $1,165,463 57,412
2020-12-31 $330,184 12,441